X-123198841-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000828.5(GRIA3):​c.268+12851A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 110,714 control chromosomes in the GnomAD database, including 3,820 homozygotes. There are 9,408 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 3820 hom., 9408 hem., cov: 22)

Consequence

GRIA3
NM_000828.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.758

Publications

1 publications found
Variant links:
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
GRIA3 Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability 94
    Inheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability due to GRIA3 anomalies
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000828.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
NM_000828.5
MANE Plus Clinical
c.268+12851A>G
intron
N/ANP_000819.4
GRIA3
NM_007325.5
MANE Select
c.268+12851A>G
intron
N/ANP_015564.5
GRIA3
NM_001256743.2
c.269-3795A>G
intron
N/ANP_001243672.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
ENST00000620443.2
TSL:1 MANE Select
c.268+12851A>G
intron
N/AENSP00000478489.1
GRIA3
ENST00000622768.5
TSL:5 MANE Plus Clinical
c.268+12851A>G
intron
N/AENSP00000481554.1
GRIA3
ENST00000611689.4
TSL:1
c.269-3795A>G
intron
N/AENSP00000478758.1

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
32571
AN:
110660
Hom.:
3816
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.162
Gnomad AMI
AF:
0.294
Gnomad AMR
AF:
0.393
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.256
Gnomad FIN
AF:
0.331
Gnomad MID
AF:
0.292
Gnomad NFE
AF:
0.355
Gnomad OTH
AF:
0.314
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.294
AC:
32586
AN:
110714
Hom.:
3820
Cov.:
22
AF XY:
0.285
AC XY:
9408
AN XY:
32988
show subpopulations
African (AFR)
AF:
0.162
AC:
4952
AN:
30562
American (AMR)
AF:
0.393
AC:
4088
AN:
10394
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
799
AN:
2635
East Asian (EAS)
AF:
0.197
AC:
694
AN:
3515
South Asian (SAS)
AF:
0.255
AC:
663
AN:
2595
European-Finnish (FIN)
AF:
0.331
AC:
1936
AN:
5849
Middle Eastern (MID)
AF:
0.293
AC:
63
AN:
215
European-Non Finnish (NFE)
AF:
0.355
AC:
18710
AN:
52767
Other (OTH)
AF:
0.320
AC:
482
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
810
1620
2431
3241
4051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.325
Hom.:
11811
Bravo
AF:
0.300

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.1
DANN
Benign
0.79
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4825838; hg19: chrX-122332693; API